-
Boilingpoint：
975.627℃ at 760 mmHg
-
Flashpoint：
543.84℃
-
Density：
1.162g/cm3
Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor for the treatment of patients with multiple myeloma. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
Find More Carfilzomib Intermediates>>
Current Location：
I want to comment